Advertisement
Canada markets close in 17 minutes

  • S&P/TSX

    21,767.37
    +58.93 (+0.27%)
     

  • S&P 500

    4,956.40
    -54.72 (-1.09%)
     

  • DOW

    37,923.91
    +148.53 (+0.39%)
     

  • CAD/USD

    0.7273
    +0.0009 (+0.13%)
     

  • CRUDE OIL

    83.23
    +0.50 (+0.60%)
     

  • Bitcoin CAD

    88,304.29
    +1,290.93 (+1.48%)
     

  • CMC Crypto 200

    1,383.26
    +70.64 (+5.38%)
     

  • GOLD FUTURES

    2,408.50
    +10.50 (+0.44%)
     

  • RUSSELL 2000

    1,939.64
    -3.32 (-0.17%)
     

  • 10-Yr Bond

    4.6150
    -0.0320 (-0.69%)
     

  • NASDAQ

    15,233.46
    -368.04 (-2.36%)
     

  • VOLATILITY

    18.92
    +0.92 (+5.11%)
     

  • FTSE

    7,895.85
    +18.80 (+0.24%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

  • CAD/EUR

    0.6825
    +0.0004 (+0.06%)
     
MARKETS LIVE BLOG:

S&P 500 SLIPS BELOW 5,000; NASDAQ SINKS ON NETFLIX DRAG

Fed's Goolsbee says 'It makes sense to wait' before cutting rates

Today’s Research Reports on Aphria, Centric Health, Helix BioPharma and TearLab

ACCESSWIRE

NEW YORK, NY / ACCESSWIRE / February 23, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://rdinvesting.com and get exclusive access to our numerous research reports and market updates.

RDI has Initiated Coverage Today on:

Aphria Inc.
https://rdinvesting.com/news/?ticker=APH.TO

Centric Health Corporation
https://rdinvesting.com/news/?ticker=CHH.TO

Helix BioPharma Corp.
https://rdinvesting.com/news/?ticker=HBP.TO

TearLab Corporation
https://rdinvesting.com/news/?ticker=TLB.TO

ADVERTISEMENT

Aphria's stock moved 2.28% lower Thursday, to close the day at $14.12. The stock recorded a trading volume of 1,687,604 shares, which was below its three months average volume of 5,207,770 shares. In the last year, Aphria's shares have traded in a range of 4.55 - 24.75. The share price has gained 210.33% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $18.46 is greater than its 200-day moving average of $11.26. Shares of the company are trading at a Price to Earnings ratio of 80.23. Shares of Aphria have fallen approximately 24.49 percent year-to-date.

Access RDI's Aphria Inc. Research Report at:
https://rdinvesting.com/news/?ticker=APH.TO

On Thursday, shares of Centric Health recorded a trading volume of 30,900 shares, which was below the three months average volume of 387,983 shares. The stock ended the day 2.13% lower at 0.46. The stock is currently trading 49.45% below its 52-week high with a 52-week trading range of 0.42 - 0.91. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $0.49 is below its 200-day moving average of $0.64. Shares of Centric Health have fallen approximately 11.54 percent year-to-date.

Access RDI's Centric Health Corporation Research Report at:
https://rdinvesting.com/news/?ticker=CHH.TO

Helix BioPharma's stock moved 4.44% higher Thursday, to close the day at $0.94. The stock recorded a trading volume of 500 shares, which was below its three months average volume of 7,408 shares. In the last year, Helix BioPharma's shares have traded in a range of 0.70 - 1.39. The share price has gained 34.29% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $0.87 is at its 200-day moving average of $0.87.

Access RDI's Helix BioPharma Corp. Research Report at:
https://rdinvesting.com/news/?ticker=HBP.TO

On Thursday, shares of TearLab recorded a trading volume of 7,100 shares, which was below the three months average volume of 19,206 shares. The stock ended the day 2.50% lower at 0.39. The stock is currently trading 94.75% below its 52-week high with a 52-week trading range of 0.35 - 7.43. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $0.48 is below its 200-day moving average of $1.17. Shares of TearLab have fallen approximately 17.02 percent year-to-date.

Access RDI's TearLab Corporation Research Report at:
https://rdinvesting.com/news/?ticker=TLB.TO

Our Actionable Research on Aphria Inc. (TSX:APH.TO), Centric Health Corporation (TSX:CHH.TO), Helix BioPharma Corp. (TSX:HBP.TO) and TearLab Corporation (TSX:TLB.TO) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker-dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com